Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of centrally acting drugs. Its structure supports the design of compounds targeting neurological pathways, including those for treating depression, anxiety, and other CNS disorders. The presence of both hydroxyl and methylamino groups in a constrained cyclobutane ring allows for selective interactions with biological targets, enhancing drug potency and specificity. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its rigid framework and functional group orientation.